Barclays PLC Innoviva, Inc. Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $4,188 - $5,478	-300 Reduced 75.0%	100 $2,000
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $4,089 - $4,710	300 Added 300.0%	400 $6,000
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $2,346 - $2,950	-200 Reduced 66.67%	100 $1,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $3,618 - $4,236	300	300 $4,000

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.